Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
98.90    -1.20 (-1.20%)
Bid:
99.22
Ask:
99.28
Spread: 0.06 (0.06%)
Market Cap: £57.64b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Publication of Supplementary Prospectus

24 Jul 2025 15:00

RNS Number : 4846S
Lloyds Bank PLC
24 July 2025
 

 

24 July 2025

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Supplementary Prospectus dated 24 July 2025 (the "Supplementary Prospectus") relating to the £35,000,000,000 Euro Medium Term Note Programme of Lloyds Bank plc.

The Supplementary Prospectus should be read and construed in conjunction with the prospectus dated 28 March 2025, as supplemented by the supplementary prospectus dated 2 May 2025 relating to the above programme (the "Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4846S_1-2025-7-24.pdf

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Tel: +44 (0) 20 7356 1571

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate TreasuryKristofer MiddletonHead of Term Issuance and Capital Structuring

Tel: +44 (0) 207 356 1122

Email: Kristofer.Middleton@lloydsbanking.com

 

Group Corporate Affairs:

Matt Smith

Head of Media Relations

Tel: +44 (0) 7788 352 487

Email: matt.smith@lloydsbanking.com

Lloyds Bank plc

25 Gresham Street,

London EC2V 7HN

United Kingdom

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFLFEVDSISFIE
Date   Source Headline
18th Feb 202510:33 amRNSNotice of Redemption
17th Feb 20259:05 amRNSNotification of Redemption
17th Feb 20258:46 amRNSNotification of Redemption
11th Feb 20252:53 pmRNSDirector/PDMR Shareholding
3rd Feb 202510:57 amRNSNotification of Redemption
31st Jan 20254:05 pmRNSTotal Voting Rights
13th Jan 20251:00 pmRNSDirector/PDMR Shareholding
2nd Jan 202511:00 amRNSBlock listing Interim Review
31st Dec 202410:02 amRNSTotal Voting Rights
20th Dec 20242:00 pmRNSDirector/PDMR Shareholding
20th Dec 202412:44 pmRNSNOTICE TO COVERED BONDHOLDERS
19th Dec 20248:41 amRNSNotification of Redemption
11th Dec 20242:16 pmRNSDirector/PDMR Shareholding
29th Nov 20243:08 pmRNSTotal Voting Rights
29th Nov 202411:37 amRNSNotice of Redemption
27th Nov 202410:20 amRNSNotice of Redemption
26th Nov 20249:00 amRNSBlock Listing of Shares
19th Nov 20243:19 pmRNSPublication of Suppl.Prospcts
19th Nov 202412:07 pmRNSPublication of Suppl.Prospcts
19th Nov 202412:02 pmRNSPublication of Suppl.Prospcts
14th Nov 20247:27 amRNSCompletion of £2 billion Share Buyback Programme
13th Nov 20245:53 pmRNSTransaction in Own Shares
13th Nov 20243:50 pmRNSDirector/PDMR Shareholding
12th Nov 20245:35 pmRNSTransaction in Own Shares
11th Nov 20245:45 pmRNSTransaction in Own Shares
8th Nov 20245:27 pmRNSTransaction in Own Shares
7th Nov 20245:41 pmRNSTransaction in Own Shares
6th Nov 20245:43 pmRNSTransaction in Own Shares
5th Nov 20245:39 pmRNSTransaction in Own Shares
4th Nov 20245:26 pmRNSTransaction in Own Shares
1st Nov 20245:36 pmRNSTransaction in Own Shares
31st Oct 20245:41 pmRNSTransaction in Own Shares
31st Oct 20243:51 pmRNSTotal Voting Rights
30th Oct 20245:41 pmRNSTransaction in Own Shares
29th Oct 20245:15 pmRNSTransaction in Own Shares
28th Oct 20245:24 pmRNSTransaction in Own Shares
28th Oct 20247:00 amRNSMotor Finance Update
25th Oct 20245:32 pmRNSTransaction in Own Shares
24th Oct 20245:25 pmRNSTransaction in Own Shares
23rd Oct 20245:15 pmRNSTransaction in Own Shares
23rd Oct 20242:39 pmRNSPublication of Suppl.Prospcts
23rd Oct 20241:03 pmRNSPublication of Suppl.Prospcts
23rd Oct 202412:47 pmRNSPublication of Suppl.Prospcts
23rd Oct 202411:25 amRNS2024 Q3 Interim Management Statement
23rd Oct 20247:00 amRNS2024 Q3 Interim Management Statement
22nd Oct 20245:37 pmRNSTransaction in Own Shares
10th Oct 20244:31 pmRNSDirector/PDMR Shareholding
9th Oct 20245:35 pmRNSTransaction in Own Shares
8th Oct 20245:38 pmRNSTransaction in Own Shares
4th Oct 20246:22 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.